Tempero Bio, Inc.
Last verified 2026-05-08. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $77.0Mattributed |
|---|---|
| Latest round | Funding round, $77.0M, 2025-11-04attributed |
| Founded | unknown |
| Headquarters | OAKLAND, CA |
| Industry | bio |
| Stage | unknown |
| Website | temperobio.com |
Tempero Bio is a clinical-stage biopharma developing TMP-301, an oral mGluR5 modulator, to treat substance use disorders like cocaine and alcohol addiction. It serves patients with addiction and their clinicians, advancing into Phase 2. Its edge is dampening rather than blocking glutamate signaling, validated by PET occupancy.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-11-04 | Funding round | $77.0M | undisclosed |
Detected tech stack
Google Cloud CDN, Sentry, Partytown, Vercel Speed Insights, WebsiteBuilder, Wix, Google Cloud, React, lodash .
Provenance
| Fact | Status | Basis |
|---|---|---|
| Funding round, $77.0M | attributed | sec-edgar named as publisher. No document URL on file. |
| Total raised $77.0M | attributed | sec-edgar named as publisher. No document URL on file. |
| Company existence | self-reported | temperobio.com, read 2026-05-08 |
| Description | self-reported | temperobio.com, read 2026-05-08 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
| Date | Fact | Change | Basis |
|---|---|---|---|
| 2026-09-25Latest round: seed, $77.0M, 2025-11-04 → Funding round, $77.0M, 2025-11-04, sec-edgar, No document URL on file | Latest round | seed, $77.0M, 2025-11-04 → Funding round, $77.0M, 2025-11-04 | sec-edgar, No document URL on file |
Records begin 2026-09-24. All changes